Science & technology
29 October 2026
L'ORÉAL-UNESCO For Women in Science
07 October 2026
Protecting children most at risk of severe and fatal pneumonia
15 July 2026
World-renowned vaccine expert joins Sydney ID
22 June 2026
CRC-P funding for real-time sepsis monitoring patch
24 March 2026
Leadership for good: united to end TB
At the University of Sydney, world-leading researchers are united to protect communities here in Australia, and across our region against TB
11 March 2026
Vaxosome secures NSW RNA Pipeline grant for tuberculosis vaccine
Vaxosome, a biotechnology company spun out of the University of Sydney, has secured support through the NSW RNA Pipeline Grant program to accelerate development of a next-generation mRNA tuberculosis vaccine.
19 November 2025
Sorrell-Gilbert Prize for research excellence in infectious diseases
Inaugural winners of the Sorrell-Gilbert Prize recognised for their outstanding 2024 research publications in basic science and public health research
16 October 2025
Simulating disease spread through evolution and opinion shifts
Sydney ID researchers from Engineering and Medicine and Health collaborate to explore how pathogen evolution and shifting public opinion affect disease spread
07 October 2025
SARS-CoV-2 infection: resistance is futile
This important discovery, supported by Sydney ID seed funding, sheds new light on how the virus evades immune detection
25 August 2025
Using AI to beat drug-resistant TB
Tuberculosis (TB) is the leading infectious disease killer in the world and most people with drug-resistant TB reside in Asia. AI analysis of TB genomes can help doctors to give patients optimal personalised treatment and allow public health teams to track how drug-resistant TB spreads in the community